Author Topic: Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows  (Read 660 times)

Ketua Dobbs

  • Administrator
  • Rank: Jr. Consultant
  • *****
  • Posts: 699
  • Ketua
    • DOBBS
  • Field of Practice: CLINICAL HAEMATOLOGY
  • State: Selangor
Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder.
Source: Drug reduces risk of relapse with neuromyelitis optica spectrum disorder, study shows
Let's make Bulletin Boards great again

Doctors Only Bulletin Board System (DOBBS)


 


Powered by EzPortal